| SCHEDULE OF BREAKDOWN OF SIGNIFICANT OPERATING EXPENSES |
SCHEDULE
OF BREAKDOWN OF SIGNIFICANT OPERATING EXPENSES
| | |
2025 | | |
2024 | |
| | |
Three months ended March 31, | |
| | |
2025 | | |
2024 | |
| Revenue | |
$ | - | | |
$ | 47 | |
| Cost of revenues | |
| - | | |
| 61 | |
| Gross profit (loss) | |
| - | | |
| (14 | ) |
| | |
| | | |
| | |
| Operating expenses: | |
| | | |
| | |
| Research and development by significant expense: | |
| | | |
| | |
| MSA/license fees | |
| 637 | | |
| 812 | |
| Study fees | |
| 352 | | |
| 64 | |
| Professional fees | |
| 156 | | |
| 103 | |
| Payroll and related | |
| 96 | | |
| 325 | |
| Other1 | |
| 68 | | |
| 154 | |
| Research and development | |
| 1,309 | | |
| 1,458 | |
| | |
| | | |
| | |
| General and administrative by significant expense: | |
| | | |
| | |
| Stock-based compensation | |
| 486 | | |
| 237 | |
| Payroll and related2 | |
| 394 | | |
| 532 | |
| Professional fees2 | |
| 386 | | |
| 1,285 | |
| Occupancy expense | |
| 7 | | |
| 1,901 | |
| Other2 | |
| 148 | | |
| 360 | |
| General and administrative | |
| 1,421 | | |
| 4,315 | |
| | |
| | | |
| | |
| Total operating expenses | |
| 2,730 | | |
| 5,773 | |
| | |
| | | |
| | |
| Loss from operations | |
| (2,730 | ) | |
| (5,787 | ) |
| | |
| | | |
| | |
| Forward sales contract expense | |
| (5,335 | ) | |
| - | |
| Change in fair value of warrant liabilities | |
| 1 | | |
| (70 | ) |
| Interest income (expense), net | |
| 5 | | |
| (786 | ) |
| Other expense, net | |
| (135 | ) | |
| - | |
| Total other expense, net | |
| (5,464 | ) | |
| (856 | ) |
| | |
| | | |
| | |
| Provision for income taxes | |
| (8 | ) | |
| (4 | ) |
| | |
| | | |
| | |
| Net loss | |
$ | (8,202 | ) | |
$ | (6,647 | ) |
| | |
March 31,
2025
| | |
December 31,
2024
| |
| Cash | |
$ | 1,918 | | |
$ | 1,729 | |
| 1 | Other includes certain lab supply expenses, amounts related to the close out of a former clinical
trial, allocated occupancy costs, stock-based compensation, and depreciation. |
| 2 | Other includes expenses related to insurance, information technology, travel, banking, depreciation
and other miscellaneous expenses. |
|